Summary of findings 1: Efficacy and safety of IVT lampalizumab 4‐weekly (monthly) vs sham
Loss of ≥ 15 letters BCVA at 1 year · adults with GA due to AMD
Summary of findings 1: Efficacy and safety of IVT lampalizumab… showed no clear difference in loss of ≥ 15 letters BCVA at 1 year compared with sham (moderate certainty).
1 finding from 1 review
- RR 0.86 [0.63, 1.18]2 studies · 1103 participantsModerate